
Bruck Kifle
Examiner (ID: 2332)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1202, 1624, 1611, 1622 |
| Total Applications | 3434 |
| Issued Applications | 2601 |
| Pending Applications | 222 |
| Abandoned Applications | 651 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4385510
[patent_doc_number] => 06277983
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-21
[patent_title] => 'Regioselective synthesis of rapamycin derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/670358
[patent_app_country] => US
[patent_app_date] => 2000-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4817
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/277/06277983.pdf
[firstpage_image] =>[orig_patent_app_number] => 670358
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/670358 | Regioselective synthesis of rapamycin derivatives | Sep 26, 2000 | Issued |
Array
(
[id] => 4305335
[patent_doc_number] => 06326372
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-04
[patent_title] => 'Lactam and cyclic urea derivatives useful as alpha 1a adrenoceptor antagonists'
[patent_app_type] => 1
[patent_app_number] => 9/671407
[patent_app_country] => US
[patent_app_date] => 2000-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33691
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 2101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/326/06326372.pdf
[firstpage_image] =>[orig_patent_app_number] => 671407
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/671407 | Lactam and cyclic urea derivatives useful as alpha 1a adrenoceptor antagonists | Sep 26, 2000 | Issued |
Array
(
[id] => 1419948
[patent_doc_number] => 06514964
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-04
[patent_title] => 'Fused cycloheptane and fused azacycloheptane compounds and their methods of use'
[patent_app_type] => B1
[patent_app_number] => 09/671025
[patent_app_country] => US
[patent_app_date] => 2000-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61312
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/514/06514964.pdf
[firstpage_image] =>[orig_patent_app_number] => 09671025
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/671025 | Fused cycloheptane and fused azacycloheptane compounds and their methods of use | Sep 25, 2000 | Issued |
Array
(
[id] => 4333535
[patent_doc_number] => 06313290
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-06
[patent_title] => 'Azolobenzazepine derivatives and compositions and method of use thereof'
[patent_app_type] => 1
[patent_app_number] => 9/668261
[patent_app_country] => US
[patent_app_date] => 2000-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21936
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 931
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/313/06313290.pdf
[firstpage_image] =>[orig_patent_app_number] => 668261
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/668261 | Azolobenzazepine derivatives and compositions and method of use thereof | Sep 21, 2000 | Issued |
Array
(
[id] => 4275114
[patent_doc_number] => 06323341
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-27
[patent_title] => 'Process for the continuous purification of crude .epsilon.-caprolactam'
[patent_app_type] => 1
[patent_app_number] => 9/665592
[patent_app_country] => US
[patent_app_date] => 2000-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2534
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/323/06323341.pdf
[firstpage_image] =>[orig_patent_app_number] => 665592
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/665592 | Process for the continuous purification of crude .epsilon.-caprolactam | Sep 18, 2000 | Issued |
Array
(
[id] => 695404
[patent_doc_number] => 07071199
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-07-04
[patent_title] => 'Kinase inhibitors as therapeutic agents'
[patent_app_type] => utility
[patent_app_number] => 09/663320
[patent_app_country] => US
[patent_app_date] => 2000-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26748
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/071/07071199.pdf
[firstpage_image] =>[orig_patent_app_number] => 09663320
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/663320 | Kinase inhibitors as therapeutic agents | Sep 14, 2000 | Issued |
Array
(
[id] => 1470727
[patent_doc_number] => 06407230
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-18
[patent_title] => 'Method for producing lactams using oligophosphate catalysts'
[patent_app_type] => B1
[patent_app_number] => 09/646153
[patent_app_country] => US
[patent_app_date] => 2000-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3089
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/407/06407230.pdf
[firstpage_image] =>[orig_patent_app_number] => 09646153
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/646153 | Method for producing lactams using oligophosphate catalysts | Sep 13, 2000 | Issued |
| 09/661008 | Hydroxyalkanoylaminolactams and related structures as inhibitors of ABeta protein production | Sep 12, 2000 | Abandoned |
Array
(
[id] => 4411843
[patent_doc_number] => 06300497
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-09
[patent_title] => 'Method for separating an azepine derivative from a mixture containing an amine and an azepine derivative'
[patent_app_type] => 1
[patent_app_number] => 9/623699
[patent_app_country] => US
[patent_app_date] => 2000-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1496
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/300/06300497.pdf
[firstpage_image] =>[orig_patent_app_number] => 623699
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/623699 | Method for separating an azepine derivative from a mixture containing an amine and an azepine derivative | Sep 6, 2000 | Issued |
Array
(
[id] => 4337929
[patent_doc_number] => 06333334
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-25
[patent_title] => 'Use of macrolide compounds for the treatment of ARDS'
[patent_app_type] => 1
[patent_app_number] => 9/623595
[patent_app_country] => US
[patent_app_date] => 2000-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3852
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/333/06333334.pdf
[firstpage_image] =>[orig_patent_app_number] => 623595
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/623595 | Use of macrolide compounds for the treatment of ARDS | Sep 4, 2000 | Issued |
Array
(
[id] => 1459404
[patent_doc_number] => 06426413
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-30
[patent_title] => 'Inhibitors of caspases'
[patent_app_type] => B1
[patent_app_number] => 09/654855
[patent_app_country] => US
[patent_app_date] => 2000-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21049
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/426/06426413.pdf
[firstpage_image] =>[orig_patent_app_number] => 09654855
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/654855 | Inhibitors of caspases | Sep 4, 2000 | Issued |
Array
(
[id] => 4408373
[patent_doc_number] => 06271373
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-07
[patent_title] => 'Compounds, compositions and methods for treating influenza'
[patent_app_type] => 1
[patent_app_number] => 9/654209
[patent_app_country] => US
[patent_app_date] => 2000-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6366
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 371
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/271/06271373.pdf
[firstpage_image] =>[orig_patent_app_number] => 654209
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/654209 | Compounds, compositions and methods for treating influenza | Aug 31, 2000 | Issued |
Array
(
[id] => 1388300
[patent_doc_number] => 06548494
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-15
[patent_title] => 'Tricyclic inhibitors of poly(ADP-ribose) polymerases'
[patent_app_type] => B1
[patent_app_number] => 09/653184
[patent_app_country] => US
[patent_app_date] => 2000-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64972
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/548/06548494.pdf
[firstpage_image] =>[orig_patent_app_number] => 09653184
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/653184 | Tricyclic inhibitors of poly(ADP-ribose) polymerases | Aug 30, 2000 | Issued |
Array
(
[id] => 4368212
[patent_doc_number] => 06274580
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-14
[patent_title] => 'Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus'
[patent_app_type] => 1
[patent_app_number] => 9/650470
[patent_app_country] => US
[patent_app_date] => 2000-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5816
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/274/06274580.pdf
[firstpage_image] =>[orig_patent_app_number] => 650470
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/650470 | Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus | Aug 28, 2000 | Issued |
Array
(
[id] => 1470194
[patent_doc_number] => 06407083
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-18
[patent_title] => 'Uses of novel organoselenium compounds with pro-oxidant activity'
[patent_app_type] => B1
[patent_app_number] => 09/648784
[patent_app_country] => US
[patent_app_date] => 2000-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15379
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/407/06407083.pdf
[firstpage_image] =>[orig_patent_app_number] => 09648784
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/648784 | Uses of novel organoselenium compounds with pro-oxidant activity | Aug 27, 2000 | Issued |
Array
(
[id] => 699369
[patent_doc_number] => 07067526
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-06-27
[patent_title] => '28-epirapalogs'
[patent_app_type] => utility
[patent_app_number] => 09/645967
[patent_app_country] => US
[patent_app_date] => 2000-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36282
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/067/07067526.pdf
[firstpage_image] =>[orig_patent_app_number] => 09645967
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/645967 | 28-epirapalogs | Aug 23, 2000 | Issued |
Array
(
[id] => 1289526
[patent_doc_number] => 06632814
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-14
[patent_title] => 'Dihydro-benzo(1,4)oxazines'
[patent_app_type] => B1
[patent_app_number] => 09/644308
[patent_app_country] => US
[patent_app_date] => 2000-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 95272
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/632/06632814.pdf
[firstpage_image] =>[orig_patent_app_number] => 09644308
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/644308 | Dihydro-benzo(1,4)oxazines | Aug 22, 2000 | Issued |
Array
(
[id] => 4339150
[patent_doc_number] => 06333410
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-25
[patent_title] => 'Process for the preparation and purification of thiol-containing maytansinoids'
[patent_app_type] => 1
[patent_app_number] => 9/641348
[patent_app_country] => US
[patent_app_date] => 2000-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 14003
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/333/06333410.pdf
[firstpage_image] =>[orig_patent_app_number] => 641348
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/641348 | Process for the preparation and purification of thiol-containing maytansinoids | Aug 17, 2000 | Issued |
Array
(
[id] => 4291201
[patent_doc_number] => 06211362
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-03
[patent_title] => 'Pyrroloazepine compounds'
[patent_app_type] => 1
[patent_app_number] => 9/640010
[patent_app_country] => US
[patent_app_date] => 2000-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12803
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/211/06211362.pdf
[firstpage_image] =>[orig_patent_app_number] => 640010
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/640010 | Pyrroloazepine compounds | Aug 16, 2000 | Issued |
Array
(
[id] => 4323149
[patent_doc_number] => 06331547
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-18
[patent_title] => 'Water soluble SDZ RAD esters'
[patent_app_type] => 1
[patent_app_number] => 9/639610
[patent_app_country] => US
[patent_app_date] => 2000-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4136
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/331/06331547.pdf
[firstpage_image] =>[orig_patent_app_number] => 639610
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/639610 | Water soluble SDZ RAD esters | Aug 15, 2000 | Issued |